Cargando…
Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens
Flavodoxins are small soluble electron transfer proteins widely present in bacteria and absent in vertebrates. Flavodoxins participate in different metabolic pathways and, in some bacteria, they have been shown to be essential proteins representing promising therapeutic targets to fight bacterial in...
Autores principales: | Salillas, Sandra, Sancho, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084853/ https://www.ncbi.nlm.nih.gov/pubmed/32164177 http://dx.doi.org/10.3390/ijms21051881 |
Ejemplares similares
-
Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies
por: Salillas, Sandra, et al.
Publicado: (2021) -
Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
por: González, Andrés, et al.
Publicado: (2019) -
Small Molecule Inhibitors of the Response Regulator ArsR Exhibit Bactericidal Activity against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2020) -
Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019) -
Streptococcus pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target
por: Rodríguez-Cárdenas, Ángela, et al.
Publicado: (2016)